According to the latest report by IMARC Group, titled “Japan Gene Therapy Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” provides an extensive analysis of the industry, including Japan gene therapy market trends, share, demand, and growth opportunities. The report also covers competitor and regional analysis and the latest advancements in the market. The Japan gene therapy market is projected to exhibit a growth rate (CAGR) of 16.8% during 2023-2028.
Japan Gene Therapy Market Overview:
Gene therapy is an innovative and evolving medical technique focused on modifying or manipulating genes to treat or prevent diseases. The methodology involves either replacing a mutated gene with a healthy copy, deactivating or “knocking out” a mutated gene that is functioning improperly, or introducing a new gene to fight a disease. Gene therapies are categorized into somatic cell therapy and germline therapy. The former targets somatic cells, which are not passed on to future generations, while the latter alters genes in germ cells, producing a hereditary impact. It offers several advantages, including the potential for a one-time, curative treatment for certain conditions, the capacity to target diseases with no existing treatment, and the possibility of personalized medicine tailored to individual genetic makeup.
Get Sample Copy of Report at – https://www.imarcgroup.com/japan-gene-therapy-market/requestsample
Japan Gene Therapy Market Growth:
Japan’s gene therapy market is majorly driven by the region’s robust healthcare infrastructure that provides a conducive environment for advanced therapies. Additionally, Japan’s regulatory framework is more flexible than other countries, facilitating easier market entry. Along with this, an aging population increases the demand for effective treatments for age-related diseases, many of which could be addressed by gene therapy. In line with this, the growing acceptance of personalized medicine boosts interest in gene therapy as a targeted solution. Apart from this, continual technological advancements in delivery vectors are enhancing the efficacy and safety of gene therapies, further impacting the market. Furthermore, partnerships between pharmaceutical companies and research institutions are catalyzing the development of new therapies. Therefore, it is creating a positive market outlook. Some of the other factors include rising awareness and patient advocacy, the growing government’s focus on attracting foreign investments, and the advent of CRISPR technology.
Key Market Segmentation:
Gene Type Insights:
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide Gene
- Deficiency
- Growth Factors
- Receptors
- Others
Vector Type Insights:
- Viral Vector
- Adenoviruses
- Lentiviruses
- Retroviruses
- Adeno-Associated Virus
- Herpes Simplex Virus
- Poxvirus
- Vaccinia Virus
- Others
- Non-Viral Techniques
- Naked and Plasmid Vectors
- Gene Gun
- Electroporation
- Lipofection
- Others
Delivery Method Insights:
- In-Vivo Gene Therapy
- Ex-Vivo Gene Therapy
Application Insights:
- Oncological Disorders
- Rare diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious Disease
- Others
Breakup by Region:
- Kanto Region
- Kinki Region
- Central/Chubu Region
- Kyushu-Okinawa Region
- Tohoku Region
- Chugoku Region
- Hokkaido Region
- Shikoku Region
Competitive Landscape:
The report also examines the competitive landscape within the market and offers comprehensive profiles of major key players.
Key Highlights of the Report:
- Market Performance
- Market Outlook
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
